That's not Metastatic Thyroid Cancer: Patterns of Non-malignant Radioiodine Uptake
<p>Radioactive Iodine (RAI) has been an integral part of the identification, surveillance, and treatment of the most common types of metastatic thyroid carcinoma since its first use in 1941. However, false positive uptake of RAI on whole body scintigraphy scans in tissues other than in metasta...
Wedi'i Gadw mewn:
Prif Awdur: | Daniella F Pinho (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
Imaging Journal of Clinical and Medical Sciences - Peertechz Publications,
2017-06-19.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
APOPTOSIS ROLE IN FORMING RADIOIODINE RESISTANCE IN DIFFERENTIATED THYROID CANCER
gan: K.A. GARIPOV, et al.
Cyhoeddwyd: (2020) -
Pharmacoeconomic effectiveness of lenvatinib in patients with differentiated radioiodine-resistant thyroid cancer
gan: S. K. Zyryanov, et al.
Cyhoeddwyd: (2018) -
mutations and aggressive histopathologic characteristics of radioiodine-refractory papillary thyroid cancer
gan: Ju Yeon Pyo, et al.
Cyhoeddwyd: (2024) -
Cost-Effectiveness of Apatinib and Cabozantinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
gan: Bo Shi, et al.
Cyhoeddwyd: (2022) -
In Silico Screening and Validation of PDGFRA Inhibitors Enhancing Radioiodine Sensitivity in Thyroid Cancer
gan: Xuefei Yu, et al.
Cyhoeddwyd: (2022)